MAIA Biotechnology is a clinical-stage pharmaceutical company that develops targeted therapies for cancer treatment. Its primary product candidate is a telomere-targeting agent currently being evaluated for use in lung cancer patients. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
